Teschner, A. (2022). Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy.
Chicago-Zitierstil (17. Ausg.)Teschner, Annkathrin. Use of TCR Antibody Fusion Proteins as Bispecific Agents for NK and T Cell-mediated Immunotherapy. Heidelberg, 2022.
MLA-Zitierstil (9. Ausg.)Teschner, Annkathrin. Use of TCR Antibody Fusion Proteins as Bispecific Agents for NK and T Cell-mediated Immunotherapy. 2022.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.